COL1A2 and neoplasm: The current study shows that COL1A2, followed by TIMP-1, are the most potent CAF-markers found and verified at the transcriptome and protein level across multiple CAF types, differentiating CAF from tumour epithelia and normal fibroblast in HNSC patient samples.